Pitavastatin Magnesium
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Pitavastatin Magnesium is used to treat hypercholesterolemia, hyperlipoproteinemias and hypertriglyceridemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 14, 2017. In 2024, Medicare Part D spent $4 million on Pitavastatin Magnesium across 8,859 claims for 2,520 beneficiaries.
Pitavastatin Magnesium is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $7.39 to $7.43 per EA — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$7.39 – $7.43
per EA
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Medicure International Inc manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
HMG-CoA Reductase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing PITAVASTATIN MAGNESIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZYPITAMAG 2 MG TABLET | $7.4261 per EA | -0.04% |
ZYPITAMAG 2 MG TABLET | $7.4261 per EA | -0.04% |
ZYPITAMAG 4 MG TABLET | $7.3886 per EA | 0.00% |
ZYPITAMAG 4 MG TABLET | $7.3886 per EA | 0.00% |
Frequently Asked Questions
What is Pitavastatin Magnesium used to treat?
Pitavastatin Magnesium is used to treat hypercholesterolemia, hyperlipoproteinemias and hypertriglyceridemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Pitavastatin Magnesium?
In 2024, Medicare Part D spent $4 million on Pitavastatin Magnesium across 8,859 claims for 2,520 beneficiaries.
How many Pitavastatin Magnesium products are on the market?
The Pitavastatin Magnesium drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Pitavastatin Magnesium?
NADAC reference prices for Pitavastatin Magnesium range from $7.3886 to $7.4261 per EA — a 1% difference between cheapest and most expensive.
Which manufacturers make Pitavastatin Magnesium?
1 manufacturer lists Pitavastatin Magnesium in NADAC. Ranked by number of NDCs, the largest are Medicure International Inc (4).
How has the price of Pitavastatin Magnesium changed recently?
Over the past 7 days, 0 Pitavastatin Magnesium NDCs rose and 2 fell, with a market-wide average change of -0.0%.